How To Detect Breast Cancer

ext">Breast cancer is the most common form ofyears later, another large study compared film
cancer in women and the second leading cause ofmammography with digital mammograms read
cancer deaths in American women. In 2009,with computer-aided detection software. The
approximately 194,280 patients are estimated toauthors found that diagnostic specificity
be diagnosed with invasive breast cancer, andsignificantly decreases from 90.2% to 87.2% with
62,280 with carcinoma in situ. An estimatedcomputer-aided detection, whereas sensitivity
40,610 will die of this disease. For a woman ofdoes not change. The rate of biopsy increases by
average risk, the lifetime incidence of breast19.7%. Thus, more expensive technology does
cancer is one in eight.not necessarily translate into better outcome.
Screening of asymptomatic women has beenIn women at high risk for developing breast
accredited for the decline in mortality of breastcancer, screening may also involve breast
cancer. The current recommendations from theultrasound and/or MRI (magnetic resonance
American Cancer Society for normal-risk womenimaging). High risk factors include BRCA gene
are as follows: 1) Yearly mammogram starting atcarriers, personal or strong family history of
age 40. The age at which screening should bebreast cancer, prior atypia such as ADH (atypical
stopped should be individualized by considering theductal hyperplasia) or LCIS (lobular carcinoma in
potential risks and benefits of screening in thesitu), and prior chest irradiation. Sonography may
context of overall health status and longevity; andbe useful in dense breasts. Screening ultrasound
2) Clinical breast exam every 3 years for womencan lead to biopsy in 2%-4% of women, of which
in their 20’s and 30’s, and everycarcinoma was found in 10%-16% of these
year for women 40 and older. The evidence tobiopsies. The ACR Imaging Network trial 6666 is
justify mammography for population-basedevaluating screening sonography in high-risk
screening is derived from both randomized andwomen. Breast MRI has also recently been used
several non-randomized clinical trials. Eightby clinicians in many high-risk patients. In previous
randomized trials totalling hundreds of thousandsreports, MRI resulted in biopsy in 7%-18% of
of patients include the Health Insurance Plan ofwomen, of which breast cancer was detected in
New York, four studies from Sweden, one from24%-88% of these biopsies. We do not know
the United Kingdom, and two from Canada. Theyet whether ultrasound or MRI decreases breast
US BCDDP (Breast Cancer Detectioncancer mortality in high-risk population, beyond
Demonstration Project), the largest study ofthat achieved by screening mammography.
mammography and clinical breast exam, alsoCurrently, breast MRI is also indicated in women
demonstrated that screening decreases breastwith newly diagnosed unilateral breast cancer. A
cancer mortality.recent publication showed that MRI can detect
During the past decade, advances incancer in the contralateral breast that is missed
mammography include digital techniques andby mammography and clinical examination in 3.1%
computer-aided detection. Film (non-digital)of cases. The sensitivity of contralateral breast
mammography has been estimated to haveMRI is 91%, the specificity 88%, and the negative
approximately 65-80% sensitivity at the desiredpredictive value 99%.
specificity of 90%. The investigators from theDespite the proven success of breast cancer
DMIST (Digital Mammographic Imaging Screeningscreening with mammography, many investigators
Trial) reported that the overall diagnostic accuracyin the US have noted a decline in its use. The
of digital and film mammography is similar.NHIS (National Health Interview Survey) estimates
However, digital mammograms are morefrom 2005 demonstrated a decline in
accurate in women under the age of 50 years,mammogram screening to 66%, from 70% in
pre-menopausal or peri-menopausal women, and2000. This may unfortunately explain the reported
those with radiographically dense breasts. Twodecrease in the incidence of breast cancer, i.e.